MoneyWorks4Me

Gland Pharma informs about analyst meet

22 Nov 2023 Evaluate
Pursuant to Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Gland Pharma has informed that it enclosed the schedule of the Analyst/ Institutional Investor Meeting with the Company to be held on 24 th November, 2023.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1869.95
Dr. Reddys Labs. 1205.60
Cipla 1386.95
Lupin 2129.80
Zydus Lifesciences 1166.85
View more..